FDA
has issued a new guidance of interest. This guidance is intended to assist
trading partners in standardizing the data contained in the product tracing
information that trading partners must provide, capture, and maintain…This
guidance is also intended to help trading partners understand the data elements
that should be included in the product
tracing information, particularly in situations where trading partners are
permitted by law to provide other trading partners with product tracing
information that omits certain elements that would otherwise be required. In
addition, this guidance recommends documentation practices that trading partners
can use to satisfy the product tracing requirements.
Posted by Dr. Tim Sandle
